enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Endo International - Wikipedia

    en.wikipedia.org/wiki/Endo_International

    Endo is one of the companies named in lawsuits by the states of Ohio, [42] Missouri and Mississippi [43] as responsible for the US opioid epidemic. Its 10-K statement indicates that a majority of the company's US revenue in 2016 was derived from the sale of prescription pain killers, predominantly opioids. [44]

  3. McKinsey to pay $650 million after advising opioid maker on ...

    www.aol.com/mckinsey-pay-650-million-advising...

    Global consulting firm McKinsey & Company agreed Friday to pay $650 million to resolve criminal and civil investigations into the advice it provided to opioids manufacturer Purdue Pharma. As part ...

  4. Titan Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Titan_Pharmaceuticals

    Titan's principal asset is Probuphine, [5] [6] a slow-release implant formulation of buprenorphine [7] for the treatment of opioid addiction or chronic pain. FDA Approval was granted on 26 May 2016. [8] It was licensed to Braeburn Pharmaceuticals for marketing and commercialization. [6]

  5. Consulting firm McKinsey to pay $650 million to resolve US ...

    www.aol.com/consulting-firm-mckinsey-pay-650...

    McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how ...

  6. List of off-label promotion pharmaceutical settlements

    en.wikipedia.org/wiki/List_of_off-label...

    The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...

  7. Consulting firm McKinsey to pay $650 million to resolve US ...

    www.aol.com/news/consulting-firm-mckinsey-pay...

    BOSTON (Reuters) -McKinsey & Co has agreed to pay $650 million to resolve a U.S. Department of Justice investigation into the consulting firm's work advising opioid manufacturer OxyContin maker ...

  8. Prescription monitoring program - Wikipedia

    en.wikipedia.org/wiki/Prescription_monitoring...

    Prescription drug monitoring programs, or PDMPs, are an example of one initiative proposed to alleviate effects of the opioid crisis. [1] The programs are designed to restrict prescription drug abuse by limiting a patient's ability to obtain similar prescriptions from multiple providers (i.e. “doctor shopping”) and reducing diversion of controlled substances.

  9. OxyContin maker's settlement plan divides victims of opioid ...

    www.aol.com/news/oxycontin-makers-settlement...

    The agreement by the maker of OxyContin to settle thousands of lawsuits over the harm done by opioids could help combat the overdose epidemic that the painkiller helped spark. In exchange for ...